In contrast, the lack of an effect of CD4+ T cell depletion on B16F10-ULBP2 tumor growth suggests that additional mechanisms, potentially via direct interference with NKG2D on CD8+ T cells, contribute to the suppression of anti-tumor immunity in this context (Figure 4G). The gene discussed is CD4; the disease is neoplasm.